Abstract
Although squamous cell carcinomas and endocervical adenocarcinomas comprise the overwhelming majority of malignant tumors arising in the uterine cervix, other important but less common malignant epithelial neoplasms may also occur, including adenosquamous carcinoma, adenoid basal carcinoma, “adenoid cystic carcinoma,” and undifferentiated carcinoma. These tumors often display distinctive morphology, but they may be difficult to classify and raise a broad differential diagnosis, especially in biopsy specimens and when classic morphology is not readily apparent. Like most epithelial tumors in the cervix, these tumors are predominantly (but not exclusively) associated with human papillomavirus infection.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Cervix
- Epithelial malignant tumors
- Adenosquamous carcinoma
- Adenoid basal carcinoma
- Adenoid cystic carcinoma
- Undifferentiated carcinoma
- Human papillomavirus
9.1 Adenosquamous Carcinoma
9.1.1 Definition
According to the 2014 WHO Classification of Tumours of the Female Reproductive Organs, both unequivocal malignant glandular and squamous elements must be present in order to make a diagnosis of cervical adenosquamous carcinoma [1]. These tumors are relatively uncommon neoplasms, and although the diagnostic criteria for this entity are relatively strict, varied application has led to a wide-ranging reported prevalence for this tumor type.
9.1.2 Synonyms
Originally called “mixed carcinoma” [2], however this term is no longer applied when dealing with this entity.
9.1.3 Etiology
Most but not all cervical adenosquamous carcinomas are associated with high-risk human papillomavirus infection [3,4,5,6,7]. It has been postulated that these neoplasms arise from cervical subcolumnar pluripotential reserve cells, which have the capacity to differentiate into both endocervical and squamous epithelium [8]. Interestingly, it has been shown that both tumor components of adenosquamous carcinoma—that is, both malignant glandular and squamous elements—appear to be monoclonal in origin and show identical patterns of X chromosome inactivation in addition to human papillomavirus type and physical status [9]. A subset of these tumors has been shown to demonstrate loss of ARID1A protein expression, but the significance of this finding and its role in tumor pathogenesis is not well understood in this tumor type [10].
9.1.4 Macroscopy
Adenosquamous carcinoma may present as a nodular enlargement of the cervix or as a frank exophytic mass; ulceration, hemorrhage, and necrosis also may be seen.
9.1.5 Microscopy
In order to make the diagnosis of adenosquamous carcinoma, the tumor must display unequivocal and overtly malignant glandular and squamous elements (often intimately admixed). Both elements should be morphologically distinguishable and recognizable, and both low-grade and high-grade morphology may be seen for both glandular and squamous components. High-grade glandular morphology usually takes the form of solid growth and diffuse high-grade nuclear atypia. High-grade squamous morphology typically exhibits sheet-like growth, high nuclear-to-cytoplasmic ratios, and lack of keratinization. Human papillomavirus infection-related features may be identified in the glandular component (which is most commonly of the “usual” type) while the squamous component may exhibit keratinization. Of note, precursor lesions, including high-grade squamous intraepithelial lesion, adenocarcinoma in situ, and stratified mucin-producing intraepithelial lesion, may be identified in association with the invasive adenosquamous carcinoma component.
From an ancillary test point of view, mucin histochemical stains may be used to confirm the presence of a morphologically evident glandular component. Immunohistochemically, block-like nuclear and cytoplasmic expression of p16 and positivity for high-risk human papillomavirus by in situ hybridization is seen in the majority of cases. Immunoexpression of other markers including cytokeratin 7, PAX8, p63, p40, MUC6, carbonic anhydrase IX, and HNF-1β may be variably seen in a subset of cases.
In cervical cytological preparations, malignant glandular and/or squamous elements are present (with features identical to invasive adenocarcinoma and squamous cell carcinoma, respectively), often in a necrotic and inflammatory background. Practically speaking, a definitive diagnosis of adenosquamous carcinoma is often difficult to make on cytological material alone.
Diagnostic Highlights
-
Unequivocal malignant glandular and squamous elements should be morphologically identifiable
-
A range of associated precursor lesions may be seen
-
These tumors tend to be associated with high-risk human papillomavirus infection and thus frequently demonstrate block-like p16 expression and positivity for human papillomavirus by in situ hybridization
-
Glassy cell carcinomas and mucoepidermoid carcinomas of the cervix are probably unrelated to true adenosquamous carcinomas of the cervix (See Differential diagnosis)
9.1.6 Differential Diagnosis
A number of lesions may be considered in the morphological differential diagnosis of cervical adenosquamous carcinoma (Table 9.1).
-
Tumors with squamous and glandular differentiation. The presence of mucin in an otherwise typical squamous cell carcinoma does not warrant the designation of adenosquamous carcinoma. Likewise, a typical usual-type endocervical adenocarcinoma with benign squamous metaplasia also should not be classified as an adenosquamous carcinoma. Endometrioid adenocarcinoma of the cervix with squamous metaplasia has historically been considered in the differential diagnosis of adenosquamous carcinoma, but it is now recognized that endometrioid carcinoma of the cervix is exceedingly rare and is not associated with human papillomavirus infection. Although “clear cell adenosquamous carcinoma” was previously described [11], tumors fitting this description often do not meet the stringent criteria for a diagnosis of adenosquamous carcinoma.
-
Invasive stratified mucin-producing carcinoma. This recently described neoplasm is a human papillomavirus –associated endocervical adenocarcinoma subtype which displays a relatively characteristic morphology that includes peripherally palisaded nests composed of stratified tumor cells with variable amounts of cytoplasmic mucin. Interestingly, a retrospective review of a cohort of cases originally classified as adenosquamous carcinoma demonstrated that a number of tumors in fact showed a morphology that was more consistent with the diagnosis of invasive stratified mucin-producing carcinoma.
-
Mucoepidermoid carcinoma and glassy cell carcinoma. Historically, a number of different cervical tumors have been classified under the cervical adenosquamous umbrella, including glassy cell carcinoma and mucoepidermoid carcinoma. So-called glassy cell carcinomas are described as being characteristically composed of sheets of tumor cells with abundant “ground glass” eosinophilic cytoplasm, distinct cell borders, and enlarged nuclei with prominent nucleoli; necrosis and a prominent eosinophilic and/or neutrophilic infiltrate also are often seen. Given that glassy cell carcinomas do not exhibit definitive morphologic evidence of both squamous and glandular elements, it is thought by some that these tumors should not be classified under the adenosquamous carcinoma umbrella. A recent study evaluating the histological, immunohistochemical, and clinicopathological features of a cohort of adenosquamous carcinomas included two tumors originally classified as glassy cell carcinoma. Both of these tumors were reclassified as poorly differentiated adenocarcinomas, given the lack of overt glandular or squamous differentiation and the lack of immunohistochemical expression of p63 and p40. Overall, the diagnosis of glassy cell carcinoma should be used very sparingly, if at all. Cervical mucoepidermoid carcinomas are described as being morphologically identical to those arising in salivary gland–type tissue; that is, they are classically composed of three cell types—squamoid cells, intermediate cells, and mucous cells—that do not exhibit overt glandular formation. Architecturally, they may be solid or cystic. Importantly (and in contrast to true adenosquamous carcinomas of the cervix), these tumors have not been shown to be associated with human papillomavirus infection, and they commonly harbor genetic alterations in the genes (CRTC1, MAML2) that are characteristically altered in mucoepidermoid carcinomas at other sites [12]. Thus it is thought that these tumors may in fact be a distinct entity, separate from true adenosquamous carcinomas.
9.1.7 Prognosis
Some studies have suggested that cervical adenosquamous carcinomas may behave more aggressively than pure cervical glandular or squamous malignancies [13], but others have refuted this idea [14]. In a recent study that compared adenosquamous carcinomas to some of its invasive glandular mimics in the cervix, there was no significant difference between these groups [3].
9.1.8 Cases
-
1.
A 59-year-old woman undergoes a hysterectomy after a cervical biopsy demonstrates the presence of a malignant tumor with both glandular and squamous differentiation (Fig. 9.1)
-
2.
A 56-year-old woman undergoes a biopsy of a large cervical tumor (Fig. 9.2)
-
3.
A 71-year-old woman undergoes a hysterectomy after initially presenting with vaginal bleeding; a large cervical mass was detected and a cervical biopsy showed a poorly differentiated neoplasm with a prominent inflammatory infiltrate (Fig. 9.3)
-
4.
A small cervical mass was identified in a 49-year-old woman who presented with post-coital bleeding; hysterectomy was performed after a biopsy demonstrated a neoplasm with distinctive morphological variability including areas of both squamous and mucinous differentiation (Fig. 9.4)
9.2 Adenoid Basal Carcinoma
9.2.1 Definition
Adenoid basal carcinoma is a rare low-grade carcinoma most commonly occurring in women older than 50 years of age [15], but these tumors have been reported in women as young as 20 years of age [16]. These tumors are frequently seen in association with high-grade squamous intraepithelial lesion and may occur in pure form or can be admixed with another carcinoma subtype such as carcinoma with adenoid cystic-like differentiation, squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, and small cell carcinoma.
9.2.2 Synonyms
“Adenoid basal epithelioma ” has been proposed for pure tumors without significant nuclear atypia or a stromal reaction to invasion [15, 17], but this term is not widely accepted.
9.2.3 Etiology
It has been postulated that adenoid basal carcinomas arise from pluripotential subcolumnar reserve cells. High-risk human papillomavirus infection is implicated in the pathogenesis of most tumors [18,19,20,21]. Some authors have postulated that adenoid basal lesions may be precursors to cervical “adenoid cystic carcinoma”, given that these two tumors appear to exist along a morphological continuum and often co-exist [18]. In addition, both tumor types are often identified with other carcinoma subtypes.
9.2.4 Macroscopy
Pure adenoid basal carcinomas are most commonly clinically occult (asymptomatic, no cervical mass) and are identified only at the time of microscopic examination. When admixed with another carcinoma subtype, cervical enlargement or a frank cervical mass may be identified.
9.2.5 Microscopy
Adenoid basal carcinomas are typically composed of rounded/lobulated small or large tumor nests and cords infiltrating into the cervical wall without a desmoplastic stromal reaction. The nests and cords are composed of peripherally palisaded small and uniform basaloid tumor cells with regular oval nuclei, inconspicuous or no nucleoli, and minimal mitotic activity. Glandular and squamous differentiation may be evident and central lumina with cystic dilatation and debris may be seen in some nests. Necrosis, lymphovascular invasion, and perineural invasion should not be seen in pure tumors. These neoplasms are often seen in association with high-grade squamous intraepithelial lesion and other carcinoma subtypes, especially squamous cell carcinoma. Immunohistochemically, the basaloid tumor cells should exhibit positivity for low-molecular-weight keratin, p63/p40, and p16 (nuclear and cytoplasmic expression in diffuse block-like pattern). CD117 expression , if present, should be only weak and focal. The Ki-67 proliferation index is variable, depending on the phenotype of tumor cells [22, 23]. The presence of human papillomavirus genetic material may be detected by in situ hybridization or polymerase chain reaction.
Adenoid basal carcinomas are not typically identified in cervical cytological preparations, as it usually does not involve the surface, but high-grade squamous intraepithelial lesion can be seen [24].
Diagnostic Highlights
-
Low-grade basaloid-appearing carcinoma arranged in solid or cystic nests/cords, invading into the cervical wall without a stromal response to invasion
-
Frequently associated with high-risk human papillomavirus infection and often seen underlying high- grade squamous intraepithelial lesion involving the cervical surface epithelium
-
May be seen in association with a more aggressive neoplasm therefore, sampling is critically important
9.2.6 Differential Diagnosis
Both benign and malignant lesions may enter into the differential diagnosis of adenoid basal carcinoma; care should be taken to distinguish a pure adenoid basal lesion from a more aggressive tumor with an adenoid basal component.
-
Adenoid basal hyperplasia. Adenoid basal hyperplasia shows morphological features similar to those of adenoid basal carcinoma, but it is differentiated from its invasive counterpart by its small size and superficial location [25].
-
“Adenoid cystic carcinoma”. Cervical tumors with adenoid basal and adenoid cystic differentiation share a common putative precursor and are both pathogenetically driven by high risk human papillomavirus infection. Modern studies have shown that pure adenoid cystic carcinomas of the cervix are very rare, and that it is more common for tumors with “adenoid cystic-like differentiation” to occur with other HPV-associated carcinoma types, including adenoid basal carcinoma (See Adenoid cystic carcinoma below).
-
Tumors with squamous and/or glandular differentiation. Care should be taken to distinguish an adenoid basal carcinoma with squamous or glandular differentiation from an invasive squamous cell carcinoma or adenosquamous carcinoma. Adenoid basal carcinomas most commonly form rounded tumor nests, exhibit banal nuclear features, and do not elicit a desmoplastic stromal response, whereas squamous cell and adenosquamous carcinomas are expected to more commonly infiltrate a desmoplastic stroma in irregular or jagged nests and demonstrate greater nuclear atypia. As with tumors with adenoid cystic-like differentiation, adenoid basal carcinoma may co-occur with other invasive carcinoma subtypes. Immunohistochemistry may be of some value in the evaluation of difficult cases, as residual low-molecular-weight keratin–positive basaloid cells will be evident around the periphery of adenoid basal carcinoma tumor nests with abundant squamous differentiation, whereas a true squamous cell carcinoma will lack these. In addition, the basaloid cells of adenoid basal carcinoma are expected to lack cytokeratin 7 expression, whereas the cells of an adenosquamous carcinoma should express cytokeratin 7.
-
Well-differentiated neuroendocrine tumors. Adenoid basal carcinomas with compact nest-like architecture may also be confused with primary well-differentiated neuroendocrine tumors (carcinoids) arising in the cervix. Metastatic neuroendocrine tumors also must be excluded. Both primary and metastatic neuroendocrine tumors exhibit immunopositivity for neuroendocrine markers including synaptophysin and chromogranin A; adenoid basal carcinomas do not.
-
Ectopic prostate tissue. Because it may exhibit squamous differentiation, ectopic prostate tissue may also mimic an adenoid basal carcinoma, but this lesion is usually superficial and does not infiltrate into the cervical stroma. Immunohistochemical stains including NKX3.1, prostate specific antigen and/or prostate specific acid phosphatase can be expressed in both ectopic prostate tissue and adenoid basal carcinoma and, therefore, cannot be used to differentiate between the two lesions.
9.2.7 Prognosis
When completely excised, pure adenoid basal carcinomas behave in an essentially benign fashion, and the overall prognosis is extremely favorable [1]. As such, conservative treatment is usually employed. In contrast , when admixed with another carcinoma subtype, tumor aggressiveness is largely determined by the non–adenoid basal carcinoma component.
9.2.8 Cases
-
1.
A 45-year-old woman with history of high-grade squamous intraepithelial lesion (diagnosed by cytological examination of Pap smear material) undergoes a cone biopsy (Fig. 9.5)
-
2.
A 43-year-old woman underwent a hysterectomy for the treatment of abnormal uterine bleeding attributed to multiple uterine fibroids (Fig. 9.6)
9.3 Carcinoma with Adenoid Cystic-Like Features
9.3.1 Definition
True adenoid cystic carcinoma of the cervix likely does not exist and is no longer recognized as a distinct entity in the 2020 WHO Classification of Tumors of the Female Genital Tract. Rather, tumors can show adenoid cystic-like features. These are rare tumors and have been reported to most often occur in women older than 40 years of age, with an average age of diagnosis between 60 and 70 years [26]. Adenoid cystic-like morphology may be very rarely pure or, more commonly, be admixed with another carcinoma subtype (“mixed carcinoma with adenoid cystic-like differentiation”) [27].
9.3.2 Synonyms
Not applicable.
9.3.3 Etiology
Like their adenoid basal carcinoma counterpart, cervical carcinoma with adenoid cystic-like features are thought to arise from cervical pluripotential subcolumnar reserve cells [18]. This putative shared origin explains why cervical tumors with adenoid cystic-like differentiation may co-occur with adenoid basal carcinomas, in addition to other carcinoma subtypes. High-risk human papillomavirus infection is thought to play a pathogenic role in most tumors, particularly those that co-occur in a mixed fashion with other tumor types [28]. “True” adenoid cystic carcinomas lack this association with human papillomavirus [27] but, have the characteristic (t6;9)(MYB-NFIB) gene fusion seen in adenoid cystic carcinomas of the salivary gland, breast, and even vulva [29]. Interestingly, HPV-related carcinomas with adenoid cystic-like features that show a varied morphology and lack the characteristic MYB-NFIB fusion have also been described in the sinonasal tract (“HPV-related multiphenotypic sinonasal carcinoma”). Although they may be morphologically similar, cervical adenoid cystic-like carcinomas are, in fact, biologically distinct from their “true” counterparts occurring in other parts of the body.
9.3.4 Macroscopy
These tumors have most often been reported to present as a palpable, hard mass. The tumor may be ulcerated or friable.
9.3.5 Microscopy
Tumors with adenoid cystic-like features commonly show the prototypical features associated with adenoid cystic carcinomas occurring outside of the genital tract. These tumors are composed of heterogeneous tubular and cribriform (“punched out” or “sieve-like”) arrangements with eosinophilic hyaline (basement membrane) or basophilic/myxoid-appearing material. Solid architecture and/or peripheral palisading may be prominent [30]. The tumor cells are basaloid and display hyperchromatic and angulated nuclei without obvious nucleoli. In contrast to their counterpart in the salivary gland, cervical carcinomas with adenoid cystic-like features may lack or show minimal myoepithelial cells . Necrosis, perineural invasion, and lymphovascular invasion may be prominent. Tumors may be seen in association with high-grade squamous intraepithelial lesion and may occur as a component of a mixed carcinoma with adenoid basal carcinoma, squamous cell carcinoma, small cell carcinoma, and others.
From an ancillary testing point of view, a Periodic acid-Schiff histochemical stain may be used to highlight the basement membrane material. Immunohistochemically, the tumor cells may variably express epithelial membrane antigen, low-molecular-weight keratin, and S100. CD117 expression has been reported in some tumors, particular those existing as a component of a mixed carcinoma [31]. Collagen IV and laminin immunohistochemistry may be used to highlight the extracellular basement membrane material. MYB immunopositivity has been reported in some mixed carcinomas [32]. Block-like nuclear and cytoplasmic expression of p16 and positivity for human papillomavirus by in situ hybridization will be seen in tumors with adenoid cystic-like differentiation, in contrast to pure adenoid cystic carcinomas [27]. Cytologically, these may be challenging to identify, as they typically do not involve the surface; high-grade squamous intraepithelial lesions may be seen in addition to three-dimensional cell clusters with acini-like architecture and irregular , angulated nuclei with coarse and granular chromatin [33].
Diagnostic Highlights
-
Basaloid tumor cells with cribriform, tubular, or solid architecture and extracellular eosinophilic (basement membrane) and/or basophilic/myxoid-appearing material
-
May occur as a component of a mixed carcinoma; human papillomavirus plays a pathogenetic role in mixed carcinomas which show adenoid cystic-like differentiation
9.3.6 Differential Diagnosis
As previously discussed, carcinoma of the cervix with adenoid cystic-like features may occur in pure form or as a component of a mixed carcinoma (“mixed carcinoma with adenoid cystic-like features”); adequate sampling and diligent microscopic examination are needed to distinguish these biologically distinct entities.
-
Basaloid-appearing neoplasms. Given that tumors with adenoid cystic-like differentiation exhibit a predominant basaloid morphology, a number of other basaloid-appearing neoplasms should be kept in the differential diagnosis including adenoid basal carcinoma, basaloid squamous cell carcinoma, and high-grade neuroendocrine carcinoma (Table 9.2) [34]. Of course, tumors in the differential diagnosis may all co-occur in the context of adenoid cystic-like differentiation. Immunohistochemical evaluation may be necessary to distinguish a tumor with adenoid cystic-like differentiation with solid architecture from basaloid squamous cell carcinoma or high-grade neuroendocrine carcinoma (both small-cell and large-cell types). Depending on the clinical scenario, basaloid-appearing metastases and some exceedingly rare primary tumors (such as extrarenal Wilms tumor) should also be considered [35].
9.3.7 Prognosis
These tumors behave aggressively and often display a propensity for local recurrence and distant metastases.
9.3.8 Cases
-
1.
A 71-year-old woman presents with a 2-month history of vaginal bleeding. Bimanual examination revealed an enlarged and firm cervix, and speculum examination showed that the cervix was mostly replaced by an ulcerated mass. The patient was sent for urgent colposcopic examination and biopsy (Fig. 9.7)
-
2.
A 68-year-old woman underwent hysterectomy after a cervical biopsy revealed the presence of an infiltrative basaloid neoplasm (Fig. 9.8)
9.4 Undifferentiated Carcinoma
9.4.1 Definition
Undifferentiated carcinoma of the cervix is a very rare lesion [1], and little has been described in the literature concerning this entity. As its name suggests, this tumor is an undifferentiated epithelial neoplasm that does not show any evidence of glandular, squamous, or neuroendocrine differentiation, either morphologically or by immunohistochemical evaluation. These neoplasms may occur in isolation or can be associated with a more well-differentiated tumor component.
9.4.2 Synonyms
Not applicable.
9.4.3 Etiology
Undifferentiated carcinomas of the cervix are of epithelial origin and may represent a “de-differentiated” component of a more well-differentiated carcinoma. Most will be associated with oncogenic human papillomavirus infection [36].
9.4.4 Macroscopy
The cervix may be bulky or may be involved by a frank mass; ulceration, hemorrhage, and necrosis may be prominent.
9.4.5 Microscopy
Undifferentiated carcinomas are composed of sheets of often discohesive enlarged cells with variable amounts of cytoplasm, highly irregular nuclei, and often prominent nucleoli. True glandular, squamous, and neuroendocrine differentiation should not be morphologically evident. No evident mucin should be identified by routine examination or by evaluation with mucin histochemical stains. These tumors may be seen in isolation, adjacent to or as a component of a more well-differentiated carcinoma, or as a component of a carcinosarcoma. A background inflammatory infiltrate may be prominent [37].
Epithelial origin should be confirmed by epithelial membrane antigen and cytokeratin expression; expression may be focal and/or weak. Block-like nuclear and cytoplasmic expression of p16 and positivity for human papillomavirus DNA or RNA by in situ hybridization may be used to definitively localize the tumor to the cervix. Distinct lack of expression for markers of squamous differentiation (34βE12, cytokeratin 5/6, p63, p40) or neuroendocrine differentiation (synaptophysin, chromogranin A) is typical.
Diagnostic Highlights
-
Undifferentiated carcinoma is rare in the cervix and is essentially a diagnosis of exclusion; a primary tumor in the uterine corpus or lower uterine segement should be excluded
-
May be a component of a “de-differentiated” carcinoma
-
Expression of epithelial membrane antigen and cytokeratins may be focal and weak
-
p16/human papillomavirus positivity can be used to localize the tumor to the cervix; otherwise, involvement of the cervix by a tumor centered in the corpus/lower uterine segment or other various high grade and/or undifferentiated neoplasms should be considered (See Differential diagnosis)
9.4.6 Differential Diagnosis
-
Various high-grade and/or undifferentiated neoplasms. Given the undifferentiated and high-grade nature of undifferentiated carcinoma of the cervix, a number of malignant neoplasms may enter the differential diagnosis, including primary poorly differentiated carcinomas of squamous, glandular, or neuroendocrine origin; mesenchymal neoplasms; malignant melanoma; and neoplasms of hematolymphoid origin, such as high-grade lymphomas, plasma cell neoplasms , or myeloid neoplasms. Cervical involvement by upper tract drop metastases or direct involvement by undifferentiated endometrial carcinoma should also be considered, in addition to metastases to the cervix arising from non-gynecological organs. As such, the diagnosis of undifferentiated carcinoma of the cervix is essentially a diagnosis of exclusion.
9.4.7 Prognosis
Undifferentiated carcinomas are expected to behave aggressively.
9.4.8 Cases
-
1.
A 64-year-old woman with no prior history of cervical screening presents with vaginal bleeding; speculum examination shows a large, ulcerated tumor. Staging investigations showed that the tumor was confined to the cervix and that no other lesions were present (Fig. 9.9).
References
Colgan TJ, Kim KR, Hirschowitz L, McCluggage G. Other epithelial tumours. In: Kurman R, Carcangiu M, Herrington C, Young R, editors. WHO classification of tumours of female reproductive organs, WHO/IARC classification of tumours, vol. 6. 4th ed. Lyon, France: IARC; 2014. p. 194–6.
Cherry CP, Glucksmann A. Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix. Cancer. 1956;9:971–9.
Stolnicu S, Hoang L, Hanko-Bauer O, Barsan I, Terinte C, Pesci A, et al. Cervical adenosquamous carcinoma: detailed analysis of morphology, immunohistochemical profile, and clinical outcomes in 59 cases. Mod Pathol. 2019;32:269–79.
Yoshida T, Sano T, Oyama T, Kanuma T, Fukuda T. Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma. Virchows Arch. 2009;455:253–9.
Yamakawa Y, Forslund O, Teshima H, Hasumi K, Kitagawa T, Hansson BG. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol. 1994;53:190–5.
Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WGV, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 2000;157:1055–62.
Quddus MR, Manna P, Sung CJ, Kerley S, Steinhoff MM, Lawrence WD. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study. Hum Pathol. 2014;45:303–9.
Martens JE, Smedts F, van Muyden RC, Schoots C, Helmerhorst TJ, Hopman A, et al. Reserve cells in human uterine cervical epithelium are derived from Müllerian epithelium at midgestational age. Int J Gynecol Pathol. 2007;26:463–8.
Ueda Y, Miyatake T, Okazawa M, Kimura T, Miyake T, Fujiwara K, et al. Clonality and HPV infection analysis of concurrent glandular and squamous lesions and adenosquamous carcinomas of the uterine cervix. Am J Clin Pathol. 2008;130:389–400.
Katagiri A, Nakayama K, Rahman MT, Rahman M, Katagiri H, Ishikawa M, et al. Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix. Int J Gynecol Cancer. 2012;22:208–12.
Fujiwara H, Mitchell MF, Arseneau J, Hale RJ, Wright TC. Clear cell adenosquamous carcinoma of the cervix. An aggressive tumor associated with human papillomavirus-18. Cancer. 1995;76:1591–600.
Lennerz JKM, Perry A, Mills JC, Huettner PC, Pfeifer JD. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion. Am J Surg Pathol. 2009;33:835–43.
Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer. 2003;97:2196–202.
Shingleton HM, Bell MC, Fremgen A, Chmiel JS, Russell AH, Jones WB, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 1995;76(10 Suppl):1948–55.
Russell MJ, Fadare O. Adenoid basal lesions of the uterine cervix: evolving terminology and clinicopathological concepts. Diagn Pathol. 2006;1:18.
DePond WD, Flauta VS, Lingamfelter DC, Schnee DM, Menendez KP. Adenoid basal carcinoma of the cervix in a 20-year-old female: a case report. Diagn Pathol. 2006;1:20.
Brainard JA, Hart WR. Adenoid basal epitheliomas of the uterine cervix: a reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia. Am J Surg Pathol. 1998;22:965–75.
Grayson W, Taylor LF, Cooper K. Adenoid cystic and adenoid basal carcinoma of the uterine cervix: comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative “reserve cell” origin. Am J Surg Pathol. 1999;23:448–58.
Senzaki H, Osaki T, Uemura Y, Kiyozuka Y, Ogura E, Okamura A, et al. Adenoid basal carcinoma of the uterine cervix: immunohistochemical study and literature review. Jpn J Clin Oncol. 1997;27:437–41.
Jones MW, Kounelis S, Papadaki H, Bakker A, Swalsky PA, Finkelstein SD. The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix. Int J Gynecol Pathol. 1997;16:301–6.
Parwani AV, Smith Sehdev AE, Kurman RJ, Ronnett BM. Cervical adenoid basal tumors comprised of adenoid basal epithelioma associated with various types of invasive carcinoma: clinicopathologic features, human papillomavirus DNA detection, and P16 expression. Hum Pathol. 2005;36:82–90.
Cviko A, Briem B, Granter SR, Pinto AP, Wang TY, Yang YC, et al. Adenoid basal carcinomas of the cervix: a unique morphological evolution with cell cycle correlates. Hum Pathol. 2000;31:740–4.
Liang Y, Lü B, Zhou C. Cervical adenoid basal carcinoma: Clinicopathologic features of 9 cases with reference to CK17 and Ki-67 expression. J Low Genit Tract Dis. 2019;23:77–81.
Powers CN, Stastny JF, Frable WJ. Adenoid basal carcinoma of the cervix: a potential pitfall in cervicovaginal cytology. Diagn Cytopathol. 1996;14:172–7.
Kerdraon O, Cornélius A, Farine M-O, Boulanger L, Wacrenier A. Adenoid basal hyperplasia of the uterine cervix: a lesion of reserve cell type, distinct from adenoid basal carcinoma. Hum Pathol. 2012;43:2255–65.
Ferry JA, Scully RE. “Adenoid cystic” carcinoma and adenoid basal carcinoma of the uterine cervix. A study of 28 cases. Am J Surg Pathol. 1988;12:134–44.
Xing D, Schoolmeester JK, Ren Z, Isacson C, Ronnett BM. Lower female genital tract tumors with adenoid cystic differentiation: p16 expression and high-risk HPV detection. Am J Surg Pathol. 2016;40:529–36.
Shi H, Shao Y, Liu Q, Wang S, Lu W, Lu B. A clinicopathological and molecular analysis of cervical carcinomas with basaloid features. Histopathology. 2020;76:283–95.
Xing D, Bakhsh S, Melnyk N, Isacson C, Ho J, Huntsman DG, et al. Frequent NFIB-associated gene rearrangement in adenoid cystic carcinoma of the vulva. Int J Gynecol Pathol. 2017;36:289–93.
Albores-Saavedra J, Manivel C, Mora A, Vuitch F, Milchgrub S, Gould E. The solid variant of adenoid cystic carcinoma of the cervix. Int J Gynecol Pathol. 1992;11:2–10.
Chen T-D, Chuang H-C, Lee L. Adenoid basal carcinoma of the uterine cervix: clinicopathologic features of 12 cases with reference to CD117 expression. Int J Gynecol Pathol. 2012;31:25–32.
Shi X, Wu S, Huo Z, Ling Q, Luo Y, Liang Z. Co-existing of adenoid cystic carcinoma and invasive squamous cell carcinoma of the uterine cervix: a report of 3 cases with immunohistochemical study and evaluation of human papillomavirus status. Diagn Pathol. 2015;10:145.
Jeong J, Ha SY, Cho HY, Chung DH, An J. Comparison of cytologic characteristics between adenoid cystic carcinoma and adenoid basal carcinoma in the uterine cervix. J Pathol Transl Med. 2015;49:396–402.
Grayson W, Cooper K. A reappraisal of “basaloid carcinoma” of the cervix, and the differential diagnosis of basaloid cervical neoplasms. Adv Anat Pathol. 2002;9:290–300.
Muc RS, Grayson W, Grobbelaar JJ. Adult extrarenal Wilms tumor occurring in the uterus. Arch Pathol Lab Med. 2001;125:1081–3.
Lei J, Andrae B, Ploner A, Lagheden C, Eklund C, Nordqvist Kleppe S, et al. Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study. BMJ. 2019;365:l1207.
Mills SE, Austin MB, Randall ME. Lymphoepithelioma-like carcinoma of the uterine cervix. A distinctive, undifferentiated carcinoma with inflammatory stroma. Am J Surg Pathol. 1985;9:883–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hodgson, A. (2021). Epithelial Malignant Tumors of the Cervix: Other Epithelial Tumors (Adenosquamous Carcinoma, Adenoid Basal Carcinoma, Carcinoma with Adenoid Cystic-like Features, Undifferentiated Carcinoma). In: Soslow, R.A., Park, K.J., Stolnicu, S. (eds) Atlas of Diagnostic Pathology of the Cervix. Springer, Cham. https://doi.org/10.1007/978-3-030-49954-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-49954-9_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-49953-2
Online ISBN: 978-3-030-49954-9
eBook Packages: MedicineMedicine (R0)